Raymed Ophthalmic Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Raymed Ophthalmic
Raymed Ophthalmic Private Limited (ROPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 May 2019 (Five years and nine months 0 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shivansh Sharma, Ashish Sachdeva, Sanjiv Kansal, and Two other members serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24290CH2019PTC042483
- Company No.
042483
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Raymed Ophthalmic?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivansh Sharma  | Director | 02-May-2019 | Current |
| Ashish Sachdeva | Director | 02-May-2019 | Current |
| Sanjiv Kansal | Additional Director | 17-Aug-2021 | Current |
| Sanjay Jhamb | Director | 02-May-2019 | Current |
| Tarsem Ruby | Director | 02-May-2019 | Current |
Financial Performance of Raymed Ophthalmic.
Raymed Ophthalmic Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Raymed Ophthalmic?
In 2020, Raymed Ophthalmic had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raymed Pharmaceuticals LimitedShivansh Sharma and Tarsem Ruby are mutual person
Ojas Medical Services Private LimitedTarsem Ruby is a mutual person
Raymzon Trade Links Private LimitedShivansh Sharma and Tarsem Ruby are mutual person
- Aquavision Pharmaceuticals Private Limited
Shivansh Sharma and Tarsem Ruby are mutual person
- Ayuray Organics Private Limited
Shivansh Sharma and Tarsem Ruby are mutual person
- India Health Services Private Limited
Shivansh Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Raymed Ophthalmic?
Raymed Ophthalmic has a workforce of 82 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raymed Ophthalmic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raymed Ophthalmic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.